Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Rh Catalyzed Asymmetric Addition. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105254657B details a rhodium-catalyzed route for prostaglandin analogs, offering milder conditions and reduced toxicity for reliable supply chain integration.
Patent CN105732249A details a high-ee Rh-catalyzed route for Escitalopram intermediates. This report analyzes cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel patent CN118184524A details high-yield asymmetric synthesis of Elacestrant intermediate, offering cost reduction and supply chain reliability for API manufacturing.
Patent CN112430228B details a novel Rh-catalyzed route for chiral 2,3-dihydrobenzo[b]thiophene 1,1-dioxide, offering superior stereoselectivity and scalable manufacturing for API intermediates.